Welcome to LookChem.com Sign In|Join Free
  • or
HENAN SUNLAKE ENTERPRISE CORPORATIONSofosbuvir C22H29FN3O9P 1190307-88-0//file1.lookchem.com/cas/reactions/2021/06/01/20867484.png
qq

Communicate with Supplier:

Ms. summer
Ms. summer: What can I do for you?

Sofosbuvir C22H29FN3O9P 1190307-88-0 CAS NO.1190307-88-0

Min.Order Quantity:
1 Kilogram
Purity:
99%
Port:
China main port
Payment Terms:
D/A,D/P,T/T

Add to Inquiry Cart

Product Details

Keywords

  • Sofosbuvir
  • 1190307-88-0
  • C22H29FN3O9P

Quick Details

  • ProName: Sofosbuvir C22H29FN3O9P 1190307-88-0
  • CasNo: 1190307-88-0
  • Molecular Formula: C22H29FN3O9P
  • Appearance: detailed in specifcations
  • Application: Aripiprazole Intermediate functional...
  • DeliveryTime: within 5days
  • PackAge: as needed
  • Port: China main port
  • ProductionCapacity: 500 Metric Ton/Month
  • Purity: 99%
  • Storage: Keep in dry and cool condition
  • Transportation: by air or sea
  • LimitNum: 1 Kilogram
  • MF: C13H21O3PS

Superiority

our services

1.certificate of analysis (coa)

2.material safety data sheet (msds)

3.route of synthesis (ros)

4.method of aanlysis (moa)

5.nuclear magnetic resonance (nmr)

6.packing pictures and loading video before loading

7.free sample

9.factory audit

10.strong after-sale service

company information

henan sunlake enterprise corporation is located in henan province , the central plain of china , which enjoys favorable geogeaphical position and convenient transportion, the com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .sunlake is a professional manufacturer engaged in producing and selling chemicals,including organic & inorganic chemicals , pigments & dyestuffs , water treatment chemicals , food & feed additives and others . these products have been being well exported to europe , southeast asia , the middle east , africa , south america and some other countries and areas.we sincerely welcome foreign friends to visit our plant for cooperation. with the idea of "quality first,credit priority, excellent service", we are highly acknowledged by customers for good quality and competitive price. more importantly , the company has a strong r & d team, who are professional engineers and scholars with ph. d. .so we are confident to serve you better with our high - quality products and professional team.we are taking great efforts to provide our customers with demanded goods and professional services, and continuously improve our core ability of competition and get the momentum for sustainable development, and finally make us being a reliable and professional wupplier in international market.we welcome any serious inquiries from all customers of the world, and sincerely hope to cooperate.

Details

sofosbuvir basic information
oral drug for hepatitis c
product name: sofosbuvir
synonyms: gs-7977;n-[[p(s),2'r]-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-l-alanine 1-methylethyl ester;psi 7977;sofosbuvir;gs-7977/sofosbuvir;sofosbuvir, psi7977;(s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate;psi-7977 discontinued
cas: 1190307-88-0
mf: c22h29fn3o9p
mw: 529.4525242
einecs: 11-000-0
product categories: psi7977;pharmaceutical intermediate;api;inhibitors
mol file: 1190307-88-0.mol
sofosbuvir structure
sofosbuvir chemical properties
density 1.41
safety information
msds information
sofosbuvir usage and synthesis
oral drug for hepatitis c sofosbuvir is also called sovaldi, is the world's first oral drug for hepatitis c, was approved one of the most important new drugs in the united states in 2013. when used in a specific therapy for chronic hepatitis c genotype, it can eliminate the traditional injection drug interferon (ifn) in demand, successful developed by the world's largest manufacturer of anti-hiv drugs - gilead sciences company in the united states, its english name is sofosbuvir, sovaldi, its global sales peak might exceed $10 billion.
on december 6, 2013, the united states food and drug administration (fda) approved sofosbuvir (sovaldi) for the treatment of chronic hepatitis c virus (hcv) infection. sofosbuvir is first used in the treatment of certain types of hcv infection without the need for safe and effective drugs at the same time the use of interferon.
hepatitis c is a viral disease that can cause inflammation of the liver, cause liver function abate or liver failure. most of the patients with hcv infection until liver damage becomes more obvious symptoms, this process may take several years. some chronic hcv infection, many years later, there will be a scar and cirrhosis of the liver and can cause bleeding, jaundice (eyes or skin yellow), liver ascites, complications such as infection or liver cancer. according to the centers

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Related Products

Related Keywords

Inquiry Cart 0